Cellebrite DI Ltd. (CLBT) reported Q3 EPS of $0.01, $0.04 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $71.7 million versus the consensus estimate of $72.13 million.
GUIDANCE:
“We are proud to deliver ARR growth of 35% year-on-year during the third quarter reflecting a strong demand market for our Digital Intelligence solutions. However, given the strengthening of the USD to the European and other currencies we expect to finish FYE 2022 at the lower end of our guidance” said Dana Gerner, Chief Financial Officer of Cellebrite.
“We remain focused on efficiently investing in our innovations and solutions to deliver on our targets for the year we outlined last quarter,” Gerner concluded.